COVID-19
Scientists urge World Health Organization to reconsider stance on COVID-19 airborne spread
July 7, 2020Manufacturing and Production COVID-19, WHO, coronavirusm
239 scientists from over 30 countries are urging the World Health Organization to put more focus on assessing the possible …
Emergent forges five-year partnership to produce one billion doses of Janssen’s COVID-19 vaccine
July 7, 2020Manufacturing and Production COVID-19, Emergent, J&J, JJ, Janssen, coronavirus
As many pharma firms move to secure upscaled manufacturing capacity for their potential COVID-19 vaccines, Johnson & Johnson’s Janssen has …
Tesla to offer “microfactories” to scale up production of CureVac’s potential COVID-19 vaccine
July 6, 2020Manufacturing and Production, Sales and Marketing COVID-19, CureVac, Vaccine, tesla
Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly …
WHO halt coronavirus trials of hydroxychloroquine, lopinavir and ritonavir
July 6, 2020Sales and Marketing COVID, COVID-19, WHO, coronavirus
The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments. This was …
US anti-racism protests did not cause spike in coronavirus cases, new study shows
July 3, 2020Medical Communications COVID-19, coronavirus
Widespread protests against racism and police brutality did not cause a significant spike in coronavirus cases in the US, according …
Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate
July 3, 2020Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …
Texas mandates the wearing of facemasks in public
July 3, 2020Medical Communications COVID-19, coronavirus
Texas becomes the latest state in the US to mandate the wearing of facemasks in public, as COVID-19 cases skyrocket …
Top Ten most popular articles on Pharmafile.com this week
July 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10
Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …
EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients
July 2, 2020Research and Development COVID-19, Eusa Pharma, siltuximab
Efforts push on to discover an effective treatment for COVID-19 in more than 100 different drug candidates worldwide. EUSA Pharma …
UK Government accused of withholding Pillar 2 COVID-19 data which show Leicester had 10 times more cases than reported pre-lockdown
July 1, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19, UK
The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …
Pharmafile.com’s weekly COVID-19 news round-up
July 1, 2020Research and Development COVID-19, coronavirus
COVID-19 vaccines dominate this week’s news cycle, with Vaxart announcing the selection of its lead candidate for COVID-19 by Operation …
US buys most of the world’s stock of COVID-19 drug remdesivir
July 1, 2020Research and Development COVID-19, coronavirus
The US has bought most of the world’s stock of the drug remdesivir which is one of the only drugs …
FDA says COVID-19 vaccine would need to be at least 50% effective to be approved
July 1, 2020Research and Development COVID-19, FDA, coronavirus
The FDA announced that any COVID-19 vaccine that gets approval must show that it is at least 50% more effective …
India to go ahead with human trials of COVID-19 vaccine in July
June 30, 2020Manufacturing and Production COVID-19, Vaccine, coronavirus
A trial of a new Indian made vaccine will begin testing in humans from July. The vaccine is called Covaxin …
The July/August 2020 issue of Pharmafocus is available to read free online now!
June 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Pharmafocus, pharma
The July/August 2020 issue of Pharmafocus is available to read free online now!
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
